Proteasome-mediated degradation of IκBα and processing of p105 in Crohn disease and ulcerative colitis
J. Clin. Invest. Alexander Visekruna, et al. 116:3195 doi:10.1172/JCI28804 [Go to this article.]

Figure 3
Expression of immunoproteasomes in the intestinal mucosa of IBD patients. (A and B) Immunofluorescent staining of sections from the terminal ileum (A) and colon (B) of IBD patients and controls with an antibody to β2i. Magnification, ×200 (A, upper panel); ×1000 (A, lower panel, and B). (C) Inflammation scores of patients shown in A and B (CD, n = 10; UC, n = 8; control, n = 10; ***P < 0.001 compared with control).